Deadline date for abstract submission: 31 Aug 2017 30th Sept 2017

Date of release acceptance letters: 15 Oct 2017

Pre-registration date deadline: 30 Oct 2017

Plenary Lectures

List of Plenary Speakers and their short resume


Professor Emeritus Geoffrey A. Cordell

Professor Emeritus Geoffrey A. Cordell obtained his Ph.D. in synthetic natural product chemistry at the University of Manchester, and served as a teacher, researcher, and senior administrator at the University of Illinois at Chicago for over 35 years. He has about 600 professional publications, is the author of three books, the editor of 37 books, and has traveled and lectured extensively all over the world.

He is currently on the Editorial Boards of 30 international journals, and serves as an advisor and consultant to international agencies, governments, academic institutions, and corporations world-wide. He is an Honorary Professor at universities in China, India, and the Philippines, and a Visiting Professor at Universities in Brasil, Colombia, Malaysia (4 universities), the Philippines, Peru, Mexico, and Japan.

He is a Fellow of the Royal Chemical Society, the Linnean Society of London, the American Association of Pharmaceutical Scientists, and the American Society of Pharmacognosy (ASP), where he is also an Honorary Member. He was recently named as Outstanding International Ethnopharmacologist for 2015 by the Society for Ethnopharmacology. His current research interests include the sustainability, non-invasive analysis, and quality control of traditional medicines, the chemistry and biosynthesis of alkaloids, and the use of vegetables as chemical reagents.

He is currently preparing books on alkaloid biosynthesis, on sustainable medicines, and on ecopharmacognosy. His recently published book with Professor Shinji Funayama, is called ìAlkaloids: a Treasury of Poisons and Medicinesî. He has over 20,500 citations, an h-index of 66, and an i10-index of 408.


Prof. Jean-Luc Wolfender

Prof. Jean-Luc Wolfender is a chemist, who completed a PhD in pharmacognosy with Prof. Kurt Hostettmann (University of Lausanne, Switzerland, 1993). After being responsible of the analytical services of this laboratory, he performed his postdoc with Prof. Al Burlingame on Conus venom profiling (UCSF, San Francisco). He is now full Professor at the Phytochemistry and Bioactive Natural Product research unit of the School of Pharmaceutical Sciences of the University of Geneva (Switzerland), where is presently the president of the School.

He has been strongly involved in the 90s in the introduction of LC‐MS and LC‐ NMR for the profiling of crude plants extracts for dereplication purposes in natural product based drug discovery research programs. He is currently developing innovative MS‐ and NMR‐ based metabolomics strategies in the frame of projects related to phytochemistry, microbial interactions and phytotherapy. He is specialised in the de novo structure identification of biomarkers at the microgram scale and is using a miniaturised approach that combines activity‐based HPLC profiling and high content information bioassays such as those involving zebrafish.

His main research interests are focused on the search of novel inducible bioactive natural products in response to various biotic and abiotic stimuli as well for the study of the mode of action of phytopharmaceuticals from a systems biology perspective. He has many collaborations with South America and Asia mainly in relation with bioactivity guided isolation studies for the discovery of novel natural products of therapeutic interest and his involved in the organisation of workshops for the promoting metabolomics with the natural product community.


Prof Ibrahim Jantan

Senior Professor in Natural Products and Medicinal Chemistry at the Faculty of Pharmacy, Universiti Kebangsaan Malaysia (UKM); President of the Malaysian Natural Products Society (since 2010); Founding Dean, Faculty of Pharmacy, UKM; Head of Bioactive Natural Product Research Cluster, UKM; Head of Drug Discovery Cluster, Agriculture: Herbal subsector, Ministry of Agriculture, Malaysia; Board member of Asian Association School of Pharmacy (AASP); Malaysian Focal Point for Medicinal Plants Malaysia for Indian Ocean Rim Association (IORA) RCSTT; Editor-in-Chief of Journal of Asian Association School of Pharmacy.

He received his B. Pharmacy (Hon.) in 1980 from the University of Mansoura, Egypt and MSc. (Medicinal Chemistry) from the University of Minnesota, USA in 1985. He obtained his Ph.D. in the field of Natural Products Chemistry from the University of Malaya, Malaysia in 1993.

His research interests include identification of chemical leads from natural products for specific therapeutic efficacy (cardiovascular protective, immunomodulatory, anti-inflammatory, PAF antagonist & antimicrobial activities) leading to the development of new drug candidates against complex and challenging drug targets prior to clinical trials. He has published more than 160 papers in indexed journals; 74 papers in proceedings; 2 books; 5 chapters in books. Google Scholar Citation index 2303; h-index 25; i10-index 80


Prof Kazuki Saito

Prof Kazuki Saito obtained his PhD from the University of Tokyo in 1982. He currently holds the position of the Dean of Graduate School of Pharmaceutical Sciences, Chiba University, and a group director at RIKEN Center for Sustainable Resource Science, Japan. He was awarded The Prize for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, Japan, JSPP Award 2016 by the Japanese Society of Plant Physiologists, and The Pharmaceutical Society of Japan Award 2017.

He was also selected one of Clarivate Analytics (Thomson Reuters) Highly Cited Researchers in the 'Plant & Animal Science' field, and an ASPB Top Author

His research focuses on the functional genomics and biotechnology of the biosynthesis of plant natural products by employing cutting-edge genomics and metabolomics technology.


Prof Yoshinori Asakawa (Tokushima Bunri University)

Prof. Asakawa first studied biology at the Tokushima University, and then went to graduate school at Hiroshima University in 1964 and studied organic chemistry, and obtained his PhD degree there and was appointed as a research assistant. Then went as a postdoctoral fellow to the Université Louis Pasteur, France where he worked for two years with Professor Guy Ourisson, one of the most original natural product chemists worldwide.

In 1976 he moved to Tokushima Bunri University as an associate professor, and was promoted to full professor in 1981. He served twice as Dean, and since1986, Director of the Institute of Pharmacology.
Professor Asakawa is the former Editor of Phytomedicine and Spectroscopy, and serves on the editorial boards of Journal of Natural Products, Phytochemistry, Phytochemistry Letters, Planta Medica, Current Chemistry and Biology, Fitoterapia, Flavour and Fragrance Journal, Natural Product Research, Natural Product Communications, Arkivoc and Malaysian Journal of Sciences, among others. He is the president of Phytochemical Society of Asia (PSA) and of Chemistry of Terpenes, Essential Oils and Aromatics (TEAC).

Professor Asakawa has published, up to now, 674 original papers, 14 reviews and 38 books. His three books on the “Chemical Constituents in Bryophytes,” appeared in “Progress in the Chemistry of Organic Natural Products” (Springer Press) are the“bibles” for Bryophyte researchers, biochemists, phytochemists and others.

Prof Norman Lewis

Prof Norman Lewis is a Regent Professor at the Washington State University. He earned his Ph.D at the University of British Columbia in 1977. He garnered several honors such as fellowship from the Institute of Biological Chemistry and Royal Society of Edinburgh, as well as the Arthur M. and Kate Eisig-Tode Distinguished Professor.

As a researcher, he is currently interested in various aspects of phenylpropanoid metabolism, particularly on understanding vascular cell wall formation. Some of his research projects also include studies on tannin, carbohydrate and diterpenoid metabolism, as well as phenylpropanoid degradation.


Prof Iqbal Choudhary (Hilal-i-Imtiaz, Sitara-i-Imtiaz, Tamgha-i-Imtiaz)

Prof. Dr. M. Iqbal Choudhary is a Distinguish National Meritorious and Director at International Center for Chemical and Biological Sciences (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research). He is among the most prominent scientists of Pakistan, recognized for his original contributions in the fields of natural products and bioorganic chemistry. He has written and edited 59 books, most of which have been published in USA and Europe. He is also the author of over 1,020 research papers and chapters in top international science journals of the West, as well as 43 US patents. The cumulative impact factor of his publications is over 1,730. This is by far the largest number of quality publications from any scientist in Pakistan. He has been among the most cited scientists of Pakistan in last five years with citations exceeding 11,300 (h-Index: 41). He is the Volume Editor of many international book series and journals. He has served as a visiting faculty in many prestigious universities of the world, including Cornell University (New York), Purdue University (Indiana), Pennsylvania State University (Pennsylvania), Scripps Institution of Oceanography (San Diego, California), The University Rhode Island (Rhode Island) and various top Universities of UK, China, Saudi Arabia, Malaysia, Kazakhstan, and Iran.

Prof. Choudhary has skillfully used his deep understanding of chemical principles and biological processes in the discovery of a large number of fascinating molecules with potential therapeutic applications. More specifically his research group has discovered and studied new inhibitors of clinically important enzymes, which can be used to stop the molecular processes involve in the enzyme-related disorders. As a result several new classes of lead molecules were introduced to the world of science along with associated understanding of their mechanism of action. The most notable contribution of Dr. Choudhary is in broad area of Bioorganic Chemistry where he used structural diversity of natural and synthetic compounds combined with biological targets to discover lead molecules with potential to be developed as effective pharmaceutical agents. Some of the internationally recognized discoveries of his research group include the discovery of novel classes of acetylcholinesterase, urease, and a-glucosidase inhibitors. His contributions to reverse bacterial resistance to antibiotics represent seminal contributions in this important field. His research group has also discovered the two most potent antiepileptic natural products (Isooxylitones A and B), patented in USA, from a local medicinal plant Delphinium denudatum, which has attracted a major attention internationally and are currently in second phase clinical trial. His work has also resulted in a number of important scientific discoveries including the discovery of plant materials with pronounced antidiabetic, antileishmanial and cholesterol-lowering activities. Many of the structurally novel compounds, discovered by his research group, were found to have interesting pharmacological profiles, and are in different stages of development.

Prof. Choudhary has won several national and international awards, such as Hilal-e-Imtiaz, Sitara-e-Imtiaz and Tamgha-e-Imtiaz by the President of Pakistan, Pakistan Academy of Sciences Gold Medal, National Book Foundation Prize on best book and the Third World Academy of Sciences Young Scientist Prize. He received the prestigious title of “Distinguished National Professor” from the Higher Education Commission in 2004 and Meritorious Professor by the University of Karachi 2013. He is a member and fellow of many prestigious societies including Fellow of The Academy of Sciences for the Developing World, Islamic Academy of Sciences, Chemical Society of Pakistan, Royal Society of Chemistry (London) and LEAD-International. He is also the recipient of the 1st Khawarizmi International Award and Prize from the President of Islamic Republic of Iran, Economic Cooperation Organization (ECO) Award in Education by the President of Azerbaijan, and COMSTECH Award in Chemistry by the Prime Minister of Pakistan.


Prof. Hendrik Luesch

Prof. Hendrik Luesch received his Diplom in Chemistry at the University of Siegen (Germany) in 1997. He studied marine natural products chemistry at the University of Hawaii at Manoa and obtained his Ph.D. with Professor Richard E. Moore in 2002. He undertook three years of postdoctoral studies as an Irving S. Sigal Fellow at The Scripps Research Institute with Professor Peter G. Schultz in functional genomics and chemical biology.

Since 2005 he has been faculty at the University of Florida (UF) and is currently Professor and Chair of the Department of Medicinal Chemistry. He holds the endowed Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development and leads a multidisciplinary marine natural products program that integrates isolation, synthesis, pharmacology, mechanism of action and early development studies.

He is UF’s Director of the Center for Natural Products, Drug Discovery and Development (CNPD3) and is also co-founder and CSO of Oceanyx Pharmaceuticals, Inc.


Prof. Mary Garson

Prof. Mary Garson completed a PhD degree at The University of Cambridge, UK, then undertook postdoctoral research as an Overseas Research Fellow of the Royal Society in Rome, Italy, followed by a research fellowship held at New Hall, Cambridge. She then spent two years working in the pharmaceutical industry in the UK, before moving to Australia as a Queen Elizabeth II Research Fellow at James Cook University of North Queensland. She is now a Professor of Chemistry at The University of Queensland, and has completed 425 SCUBA dives for sample collection linked to research into marine natural products chemistry; the flatworm Maritigrella marygarsonae (“little female sea tiger”) is named in her honour.

During 1996-2004, she chaired the International Relations Committee of the Royal Australian Chemical Institute and was thereby a member of the National Committee for Chemistry. Between 2002-2005, she was Chair of the board of Australian Science Innovations, responsible for Australia’s teams in international science Olympiads. Mary has been appointed to Division III (organic and biomolecular) of the International Union of Pure and Applied Chemistry (IUPAC), first as a Titular Member (2006-present), then as Secretary, and eventually as Division President for the 2014-2015 biennium. She is currently the Chair of the Management Committee planning events and activities for the IUPAC Centenary in 2019, and has been elected to membership of the Bureau of IUPAC for 2018-2021.

In 2011, she created and convened a global breakfast event Women sharing a chemical moment in time for the International Year of Chemistry; over 40 countries shared their individual events with each other through social media websites. Some countries organized radio and media coverage, and a video was presented at the Opening Ceremony for IYC2011 in Paris.


Dr. Fang-Rong Chang

Professor of Pharmacognosy in the Graduate Institute of Natural Products (GINP),
Kaohsiung Medical University (KMU); Vice Dean, Office of Global Affairs, KMU.

He obtained his BS in Nutrition from Chung-Shan Medical University (Taiwan) in 1988. He then obtained his MS and PhD in Pharmacognosy from Kaohsiung Medical University (Taiwan), Pharmacognosy in 1991 and 1995, respectively.

He has more than 320 research articles in SCI refereed journals, more than 500 oral or poster presentation, reviewer of more than 110 different international journals, editorial board members of 8 international journals, authorship of several book chapters; more than 30 patents issued or in application, more than 20 industry-academic cooperation, more than 5 patent/tech transfer experiences (including one new drug R&D tech transfer).


Dr Gisela P. Concepcion

Gisela P. Concepcion is a Professor at The Marine Science Institute of the University of the Philippines Diliman where she teaches graduate courses and leads research programs on marine natural products, drug discovery and related biomedical research.

An Academician of the Philippine National Academy of Science and Technology (NAST) since 2008, Dr. Concepcion has held key positions in scientific organizations and is the founder and co-editor of the ISI-listed, on-line journal Philippine Science letters. She was also the founder and editor of the science column Star Science in the newspaper The Philippine Star. In 2015, she was elected Fellow of The World Academy of Sciences (TWAS)

Dr. Concepcion served as Vice President for Academic Affairs of the University of the Philippines System from February 2011 to February 2017. She has received wide recognition and significant awards for her scientific publications, science advocacies, and academic and science administrative work. http://msi.upd.edu.ph/~concepciongp/lab-members/principal-investigator/


Dr. Reynaldo Garcia

Dr. Reynaldo Garcia has a dual background in biomedical research and in the management of technology and innovation. He did his PhD in Molecular Biology at the Australian National University and his life science-MBA (Master’s in Bioscience Enterprise) at the University of Cambridge in England, in collaboration with the Massachusetts Institute of Technology’s Sloan School of Management. For his PhD, he was a recipient of an Equity and Merit Scholarship and an ANU PhD Scholarship. While at Cambridge, he was a recipient of an EPSRC scholarship. His did his MPhil thesis work with Dr. Janice Reichert of the Tuft’s Center for the Study of Drug Development in Boston.

Dr. Garcia did postdoctoral work in New Zealand (University of Otago Medical School), Paris (Hopital de la Pitie-Salpetriere/Universite Pierre et Marie Curie), the United States (Case Western Reserve University School of Medicine) and London (University College London), before being appointed senior research scientist at Cancer Research UK’s Beatson Institute in Scotland. He has worked on Merck- and Roche-funded projects involving characterization of drug targets for pain and development of drug screening assays. After some 15 years in the laboratory, he went to business school and later became Manager of the London Biotechnology Network.

He went back to the Philippines in 2010 and is currently Full Professor at the National Institute of Molecular Biology and Biotechnology at the University of the Philippines Diliman. He is principal investigator of the multi-awarded Disease Molecular Biology and Epigenetics Laboratory.


Ecological, Biological and Chemical Diversity Leads from Marine and Terrestrial Ecosystems for Drug Discovery and Development

Gisela P. Concepcion, The Marine Science Institute, University of the Philippines, Diliman, Quezon City, 1101, Philippines


Since the turn of the century, the incidence of infectious diseases, cancer, pain and neurodegenerative conditions has been increasing worldwide; while simultaneously, the rate at which novel drugs are being developed for these serious conditions has been decreasing. Thus, there is an urgent need to fill the drug pipeline.

The marine environment, which is home to the oldest and most successfully adapted organisms in the world, is a treasure trove of chemical and biochemical agents that mediate intimate ecological and biological interactions that ensure the survival and success of the organisms and the maintenance of a delicate balance within the ecosystem.

Likewise, the terrestrial environment provides unique habitats where plant communities thrive successfully. The Philippines is home to among the richest marine and terrestrial ecosystems in the world which could be a source of highly diverse compounds. These compounds are being explored to serve as drug leads to prevent, mitigate or cure the above serious human conditions. We have been studying the megadiverse groups of marine sponges and cone snails for several years, and more recently, other Conoideans, other mollusk groups and their associated bacteria.

We are making use of new strategies – taking leads from the ecology and biology of these organisms, from the venom transcriptomes of venomous snails, from the microbial genomes and metagenomes of associated bacterial communities - to isolate new bioactive compounds and accelerate drug discovery and development.

From a terrestrial ecosystem, we are pursuing the nutritional, nutraceutical and therapeutic applications of a highly successful plant Moringa oleifera (malunggay) which is known to grow even under adverse conditions, yet is able to produce a very rich array of macronutrients, micronutrients and bioactive secondary metabolites.